Allarity Therapeutics, Inc. 10-Q filing
Filed 2026-05-15 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001437749-26-017371
- Form type
- 10-Q
- CIK
- 0001860657
- Primary document
- https://www.sec.gov/Archives/edgar/data/1860657/000143774926017371/allr20260331_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Allarity Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-2.7M | - | - |
| Net Income | $-2.8M | - | - |
| Eps Basic | -0.17 | - | - |
| Cash And Equivalents | $19.8M | - | - |
| Total Assets | $34.9M | - | - |
| Total Liabilities | $28.0M | - | - |
| Shareholders Equity | $6.9M | - | - |
| Operating Cash Flow | $-4.5M | - | - |
| Capital Expenditures | $64,000 | - | - |